trending Market Intelligence /marketintelligence/en/news-insights/trending/kzkQKYitNvP9OHhQH3Jr1Q2 content esgSubNav
In This List

Allergan's topical cream for facial redness gets thumbs up from US FDA

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Allergan's topical cream for facial redness gets thumbs up from US FDA

The U.S. FDA approved Allergan PLC's Rhofade cream for the treatment of persistent facial redness in adults with rosacea, a common long-term skin disease.

Rhofade will be commercially available in the U.S. starting in May.